MHC Class II Derived Recombinant T Cell Receptor Ligands Protect DBA/1LacJ Mice from Collagen-induced Arthritis

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2008 Jan 8

PMID 18178865

Citations 18

Authors

Jianya Huan

Laurie J Kaler

Jeffery L Mooney

Sandhya Subramanian

Corwyn Hopke

Arthur A Vandenbark

Edward F Rosloniec

Gregory G Burrows

Halina Offner

Affiliations

Soon will be listed here.

Abstract

We previously demonstrated the therapeutic effects of MHC class II derived recombinant T cell receptor ligands (RTL), single-chain two domain complexes of the alpha1 and beta1 domains of MHC class II molecules genetically linked with an immunodominant peptide, in experimental autoimmune encephalomyelitis. In the current study, we produced a monomeric murine I-Aq-derived RTL construct covalently linked with bovine collagen type II peptide (bCII257-270) suitable for use in DBA/1LacJ mice that develop collagen-induced arthritis (CIA), an animal model of human rheumatoid arthritis, after immunization with bCII protein in CFA. In this study, we demonstrate that the I-Aq-derived RTLs reduced the incidence of the disease, suppressed the clinical and histological signs of CIA and induced long-term modulation of T cells specific for arthritogenic Ags. Our results showed that the I-Aq/bCII257-270 molecule could systemically reduce proinflammatory IL-17 and IFN-gamma production and significantly increase anti-inflammatory IL-10, IL-13, and FoxP3 gene expression in splenocytes. Moreover, I-Aq/bCII257-270 molecule could also selectively inhibit IL-1beta, IL-6, and IL-23 expression in local joint tissue. This is the first report demonstrating effective prevention of joint inflammation and clinical signs of CIA with an I-Aq-derived RTL, thus supporting the possible clinical use of this approach for treating rheumatoid arthritis in humans.

Citing Articles

Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis.

Urbonaviciute V, Romero-Castillo L, Xu B, Luo H, Schneider N, Weisse S Proc Natl Acad Sci U S A. 2023; 120(25):e2218668120.

PMID: 37307481 PMC: 10288627. DOI: 10.1073/pnas.2218668120.

Identification of the key genes and long non‑coding RNAs in ankylosing spondylitis using RNA sequencing.

Xu Z, Li H, Chen Q, Chen G Int J Mol Med. 2018; 43(3):1179-1192.

PMID: 30592273 PMC: 6365023. DOI: 10.3892/ijmm.2018.4038.

Partial MHC class II constructs as novel immunomodulatory therapy for stroke.

Benedek G, Vandenbark A, Alkayed N, Offner H Neurochem Int. 2016; 107:138-147.

PMID: 27773790 PMC: 5411346. DOI: 10.1016/j.neuint.2016.10.007.

Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules.

Park Y, Jung S, Park S BMB Rep. 2016; 49(6):331-6.

PMID: 26779996 PMC: 5070721. DOI: 10.5483/bmbrep.2016.49.6.207.

Bifunctional Peptide Inhibitors Suppress Interleukin-6 Proliferation and Ameliorates Murine Collagen-Induced Arthritis.

Buyuktimkin B, Kiptoo P, Siahaan T J Clin Cell Immunol. 2015; 5(6).

PMID: 26251760 PMC: 4524745. DOI: 10.4172/2155-9899.1000273.

References

McKenzie B, Kastelein R, Cua D . Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2005; 27(1):17-23. DOI: 10.1016/j.it.2005.10.003. View

Leung B, Sattar N, Crilly A, Prach M, McCarey D, Payne H . A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol. 2003; 170(3):1524-30. DOI: 10.4049/jimmunol.170.3.1524. View

Malmstrom V, Backlund J, Jansson L, Kihlberg J, Holmdahl R . T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis. Arthritis Res. 2000; 2(4):315-26. PMC: 17814. DOI: 10.1186/ar106. View

Murphy C, Langrish C, Chen Y, Blumenschein W, Mcclanahan T, Kastelein R . Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003; 198(12):1951-7. PMC: 2194162. DOI: 10.1084/jem.20030896. View

Thornton A, Shevach E . Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 1999; 164(1):183-90. DOI: 10.4049/jimmunol.164.1.183. View

Thomas R, McIlraith M, Davis L, Lipsky P . Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum. 1992; 35(12):1455-65. DOI: 10.1002/art.1780351209. View

Holmdahl R, Jansson L, Larsson A, Jonsson R . Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol. 1990; 31(2):147-57. DOI: 10.1111/j.1365-3083.1990.tb02754.x. View

Walker M, Kasprowicz D, Gersuk V, Benard A, Van Landeghen M, Buckner J . Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest. 2003; 112(9):1437-43. PMC: 228469. DOI: 10.1172/JCI19441. View

Michaelsson E, Andersson M, Engstrom A, Holmdahl R . Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol. 1992; 22(7):1819-25. DOI: 10.1002/eji.1830220722. View

10.

Iwakura Y, Ishigame H . The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006; 116(5):1218-22. PMC: 1451213. DOI: 10.1172/JCI28508. View

11.

Appel H, Seth N, Gauthier L, Wucherpfennig K . Anergy induction by dimeric TCR ligands. J Immunol. 2001; 166(8):5279-85. PMC: 3414419. DOI: 10.4049/jimmunol.166.8.5279. View

12.

Firestein G . The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. J Clin Invest. 2004; 114(4):471-4. PMC: 503778. DOI: 10.1172/JCI22651. View

13.

Brand D, Kang A, Rosloniec E . Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol. 2003; 25(1):3-18. DOI: 10.1007/s00281-003-0127-1. View

14.

Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H . T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol. 1985; 22(3):295-306. DOI: 10.1111/j.1365-3083.1985.tb01884.x. View

15.

Vandenbark A, Rich C, Mooney J, Zamora A, Wang C, Huan J . Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice. J Immunol. 2003; 171(1):127-33. DOI: 10.4049/jimmunol.171.1.127. View

16.

Huan J, Meza-Romero R, Mooney J, Chou Y, Edwards D, Rich C . Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity. J Chem Technol Biotechnol. 2012; 80(1):2-12. PMC: 3438139. DOI: 10.1002/jctb.1086. View

17.

Corthay A, Backlund J, Holmdahl R . Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease. Ann Med. 2001; 33(7):456-65. DOI: 10.3109/07853890109002094. View

18.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

19.

Acosta-Rodriguez E, Napolitani G, Lanzavecchia A, Sallusto F . Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007; 8(9):942-9. DOI: 10.1038/ni1496. View

20.

Kim W, Cho M, Jung Y, Min S, Park S, Min D . Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci. 2004; 327(4):202-11. DOI: 10.1097/00000441-200404000-00006. View